Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sophiris Bio Inc SPHS

Healthcare Biotechnology
Sophiris Bio Inc is a clinical-stage biopharmaceutical company. It focuses on the development of products for the treatment of urological diseases. The company's product portfolio includes topsalysin (PRX302), for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. Topsalysin is... see more

Recent & Breaking News (EXPM:SPHS)

Sophiris Bio Reports Second Quarter Financial Results and Recent Key Operational Highlights

Canada NewsWire August 5, 2013

Sophiris Bio Announces an Addition to its Board of Directors

Canada NewsWire July 15, 2013

Sophiris Bio Announces an Addition to its Board of Directors

PR Newswire July 15, 2013

Sophiris Bio Announces Changes to Board of Directors

Canada NewsWire July 12, 2013

Sophiris Bio Announces Changes to Board of Directors

PR Newswire July 12, 2013

Sophiris Bio Inc. Announces Election of Directors

Canada NewsWire June 14, 2013

Correction - Sophiris Bio Inc. Files Registration Statement for Proposed Initial U.S. Public Offering on the NASDAQ

PR Newswire February 18, 2013

Correction - Sophiris Bio Inc. Files Registration Statement for Proposed Initial U.S. Public Offering on the NASDAQ

Canada NewsWire February 18, 2013

Sophiris Bio Inc. Files Registration Statement for Proposed Initial U.S. Public Offering on the NASDAQ

Canada NewsWire February 15, 2013

Sophiris Bio Reports Fourth Quarter and Year-End 2012 Financial Results and Key Operational Highlights

Canada NewsWire February 13, 2013